ATE433755T1 - Substituierte cyclopentanone mit therapeutischer wirkung - Google Patents

Substituierte cyclopentanone mit therapeutischer wirkung

Info

Publication number
ATE433755T1
ATE433755T1 AT06750373T AT06750373T ATE433755T1 AT E433755 T1 ATE433755 T1 AT E433755T1 AT 06750373 T AT06750373 T AT 06750373T AT 06750373 T AT06750373 T AT 06750373T AT E433755 T1 ATE433755 T1 AT E433755T1
Authority
AT
Austria
Prior art keywords
therapeutic action
substituted cyclopentanones
cyclopentanones
substituted
therapeutic
Prior art date
Application number
AT06750373T
Other languages
English (en)
Inventor
Yariv Donde
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE433755T1 publication Critical patent/ATE433755T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06750373T 2005-04-18 2006-04-17 Substituierte cyclopentanone mit therapeutischer wirkung ATE433755T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67283705P 2005-04-18 2005-04-18
PCT/US2006/014319 WO2006113571A2 (en) 2005-04-18 2006-04-17 Substituted cyclopentanones for treating inflammatory bowel disease

Publications (1)

Publication Number Publication Date
ATE433755T1 true ATE433755T1 (de) 2009-07-15

Family

ID=36809206

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06750373T ATE433755T1 (de) 2005-04-18 2006-04-17 Substituierte cyclopentanone mit therapeutischer wirkung

Country Status (9)

Country Link
US (1) US7439386B2 (de)
EP (1) EP1871381B1 (de)
AR (1) AR053584A1 (de)
AT (1) ATE433755T1 (de)
DE (1) DE602006007328D1 (de)
DK (1) DK1871381T3 (de)
ES (1) ES2325634T3 (de)
TW (1) TWI386208B (de)
WO (1) WO2006113571A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855226B2 (en) 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
US20070232660A1 (en) * 2006-04-04 2007-10-04 Allergan, Inc. Therapeutic and delivery methods of prostaglandin ep4 agonists
EP2147672A4 (de) 2007-05-08 2011-11-02 Nat University Corp Hamamatsu University School Of Medicine Zytotoxischer t-zellen-aktivator mit einem ep4-agonisten
EP2392323A4 (de) 2009-01-30 2012-09-26 Univ Kyoto Progressionshemmer für prostatakrebs und verfahren zur progressionshemmung
US9394273B2 (en) 2014-05-15 2016-07-19 Allergan, Inc. Therapeutic prostaglandin receptor agonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117014A (en) * 1976-01-09 1978-09-26 Abbott Laboratories Prostaglandin derivatives
US4166452A (en) * 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US20030027853A1 (en) * 2001-06-14 2003-02-06 Allergan Sales, Inc. 3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
US6875787B2 (en) * 2003-02-11 2005-04-05 Allergan, Inc. 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
US7183324B2 (en) * 2004-11-23 2007-02-27 Allergan, Inc. 2,3,4-substituted cyclopentanones as therapeutic agents

Also Published As

Publication number Publication date
DE602006007328D1 (de) 2009-07-30
WO2006113571A3 (en) 2006-12-14
TW200719901A (en) 2007-06-01
WO2006113571A2 (en) 2006-10-26
US7439386B2 (en) 2008-10-21
AR053584A1 (es) 2007-05-09
ES2325634T3 (es) 2009-09-10
EP1871381B1 (de) 2009-06-17
DK1871381T3 (da) 2009-08-24
WO2006113571B1 (en) 2007-01-11
US20070225345A1 (en) 2007-09-27
EP1871381A2 (de) 2008-01-02
TWI386208B (zh) 2013-02-21

Similar Documents

Publication Publication Date Title
FI20041476A0 (fi) Silloittuva biopolymeeri
DE602006016920D1 (de) Lichtemittierende kunststoffverglasung
DE602005003957D1 (de) Mit doppelextrusionsverfahren hergestelltes augenimplantat
DE602006011100D1 (de) Trokar mit Befestigungsmitteln
DE502005000502D1 (de) Vernetzbare Polyorganosiloxanmassen
DE602006016573D1 (de) Substituierte piperidine
ATE383342T1 (de) Substituierte n-cyclohexylimidazolinone mit mch- modulatorischer wirkung
DE602005012822D1 (de) Nmr-hf-spulen mit aufgeteilten beweglichen kapazitätsbändern
DE502006004511D1 (de) Wabenkörper mit zerklüfteten stirnseiten
DE502006006105D1 (de) Matrize mit kleinen näpfchenartigen vertiefungen
ATE433755T1 (de) Substituierte cyclopentanone mit therapeutischer wirkung
DE502006007719D1 (de) Rektoskop mit lichtabstrahlenden Elementen
DE602006015078D1 (de) Kernplatte mit mehreren gliedern
DE102005011601A8 (de) Abreißkupplung
DE502006002399D1 (de) Tür mit türbremse
DE602005009139D1 (de) Router mit speziellen Funktionen
ATE471934T1 (de) Indazolamide mit analgetischer wirkung
DK1802635T3 (da) Heteroatomholdige tricykliske forbindelser
DE602005024176D1 (de) Thermoprozessor mit auswechselbarer muffe
DE602005015456D1 (de) Drehmechanismus mit verlängertem hub
DE602006014799D1 (de) Heilmittel gegen sensorische erkrankungen
DE202005018500U1 (de) Doppel-Universaldimmer
FI20041703A0 (fi) Sektoriloisto
DE602004011773D1 (de) Neue imidazopyridinverbindung ii mit therapeutischer wirkung
DE112004003044A5 (de) Lichtsignalanlage mit Phantomlichtunterdrückung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties